US 11,751,798 B2
Method of evaluating concomitant clinical dementia rating and its future outcome using predicted age difference and program thereof
Wen-Yih Tseng, Taipei (TW); and Yung-Chin Hsu, New Taipei (TW)
Assigned to ACROVIZ USA INC., San Francisco, CA (US)
Filed by AcroViz USA Inc., San Francisco, CA (US)
Filed on Nov. 22, 2022, as Appl. No. 17/992,005.
Application 17/992,005 is a continuation of application No. 17/704,287, filed on Mar. 25, 2022, granted, now 11,589,800.
Claims priority of provisional application 63/216,028, filed on Jun. 29, 2021.
Prior Publication US 2023/0086483 A1, Mar. 23, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); G06T 7/00 (2017.01); A61B 5/055 (2006.01)
CPC A61B 5/4088 (2013.01) [A61B 5/055 (2013.01); A61B 5/7275 (2013.01); G06T 7/0012 (2013.01); G06T 2207/10092 (2013.01); G06T 2207/30016 (2013.01)] 17 Claims
OG exemplary drawing
1. A non-transitory computer readable medium storing a program causing a computer to execute a process for quantitatively evaluating a cognitive status and its future change from a medical image of an individual's brain, the process comprising:
(1) acquiring at least one medical brain image;
(2) processing the medical brain image to obtain at least one feature of the image;
(3) using a pre-established prediction model to determine a condition of the cognitive status and predict its future change based on the at least one feature obtained;
wherein the pre-established prediction model comprises at least a brain age model.